Vietnam To Review Approval Process For Merck and GSK Cancer Vaccines After Reports Of Unethical Lobbying, Efficacy Concerns
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Vietnam's Ministry of Health has decided to review the approval process of two cervical cancer vaccines -Gardasil of Merck Sharp & Dohme and GlaxoSmithKline's Cervarix, the ministry announced Dec. 17